Michael Haber





I am a Professor in the Department of Biostatistics and Bioinformatics at the Rollins School of Public Health, Emory University, and I have served in this role for the past 28 years. I earned my doctoral degree and my Master of Science degree in Statistics from the Hebrew University of Jerusalem. I have extensive experience in both development and application of statistical methods to analyze various types of data from experimental and observational studies. Over the past 35 years, I have been actively engaged in research on stochastic models and statistical methods for infectious diseases. My colleagues and I have developed models and statistical methods to estimate transmission parameters as well as direct, indirect and overall effects of vaccines and vaccination programs. These methods have been applied to data from observational studies and clinical trials on influenza, rotavirus gastroenteritis, measles, mumps, HIV, and other infectious diseases. Throughout the past 15 years I have worked with scientists from the Division of Influenza, Centers for Disease Control and Prevention (CDC), and faculty from the Emory University Department of Infectious Diseases on models and methods for evaluation of vaccination and other interventions against influenza. My recent research focuses on estimation of the effectiveness of influenza vaccination. From 2014 to 2018 I was the Principal Investigator on an NIH/NIAID grant (R01 AI110474) entitled ‘Study Designs for Estimating the Effectiveness of Vaccination against Influenza’. In this research project my colleagues and I focused on assessing the bias of vaccine effectiveness estimates from various types of observational studies. One of the papers resulting from this research project addresses issues in evaluating vaccine effectiveness from test-negative studies conducted during an influenza pandemic. Currently I am Principal Investigator on a CDC-funded project on evaluation of waning effectiveness of rotavirus vaccines

Preferred Pronouns


Personal Academic Website

Research/Topics of Interest

Agent-based models
Apply models to public health
Clinical trail design
Compartmental models
New methods development
Public health application of models
Public health policy/interventions
Statistical models
Surveillance/case detection
Study design
Vaccine effectiveness
Statistical methods

Pathogens/Diseases of Main Interest/Expertise

Diarrheal diseases
Pandemic influenza
Respiratory diseases
Season influenza
Vaccine-preventable diseases

Countries of Work/Collaboration

United States



Nye JA, Piccinelli M, Hwang D, Cooke CD, Paeng JC, Lee JM, Cho SG, Folks R, Haber M, Bom HS, Koo BK, Garcia EV. (2021). Determination of [N-13]-ammonia extraction fraction in patients with coronary artery disease by calibration to invasive coronary and fractional flow reserve. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology

Haber M, Tate JE, Lopman BA, Qi W, Ainslie KEC, Parashar UD. (2021). Comparing statistical methods for detecting and estimating waning efficacy of rotavirus vaccines in developing countries. Human vaccines & immunotherapeutics

Baker JM, Tate JE, Leon J, Haber MJ, Pitzer VE, Lopman BA. (2020). Post-vaccination serum anti-rotavirus immunoglobulin A as a correlate of protection against rotavirus gastroenteritis across settings. The Journal of infectious diseases

Ainslie KEC, Haber M, Orenstein WA. (2019). Challenges in estimating influenza vaccine effectiveness. Expert review of vaccines, 18(6)

Ainslie KEC, Haber M, Orenstein WA. (2019). Bias of influenza vaccine effectiveness estimates from test-negative studies conducted during an influenza pandemic. Vaccine, 37(14)

Haber M, Lopman BA, Tate JE, Shi M, Parashar UD. (2019). Effect of propensity of seeking medical care on the bias of the estimated effectiveness of rotavirus vaccines from studies using a test-negative case-control design. Vaccine, 37(24)

Baker JM, Tate JE, Leon J, Haber MJ, Lopman BA. (2019). Antirotavirus IgA seroconversion rates in children who receive concomitant oral poliovirus vaccine: A secondary, pooled analysis of Phase II and III trial data from 33 countries. PLoS medicine, 16(12)

Baker JM, Tate JE, Steiner CA, Haber MJ, Parashar UD, Lopman BA. (2019). Longer-term Direct and Indirect Effects of Infant Rotavirus Vaccination Across All Ages in the United States in 2000-2013: Analysis of a Large Hospital Discharge Data Set. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 68(6)

Ainslie KEC, Shi M, Haber M, Orenstein WA. (2019). A Dynamic Model for Evaluation of the Bias of Influenza Vaccine Effectiveness Estimates From Observational Studies. American journal of epidemiology, 188(2)

Haber M, Lopman BA, Tate JE, Shi M, Parashar UD. (2018). A comparison of the test-negative and traditional case-control study designs with respect to the bias of estimates of rotavirus vaccine effectiveness. Vaccine, 36(33)

Ainslie KEC, Shi M, Haber M, Orenstein WA. (2017). On the bias of estimates of influenza vaccine effectiveness from test-negative studies. Vaccine, 35(52)

Shi M, An Q, Ainslie KEC, Haber M, Orenstein WA. (2017). A comparison of the test-negative and the traditional case-control study designs for estimation of influenza vaccine effectiveness under nonrandom vaccination. BMC infectious diseases, 17(1)

Ainslie KEC, Haber MJ, Malosh RE, Petrie JG, Monto AS. (2018). Maximum likelihood estimation of influenza vaccine effectiveness against transmission from the household and from the community. Statistics in medicine, 37(6)

Foppa IM, Ferdinands JM, Chaves SS, Haber MJ, Reynolds SB, Flannery B, Fry AM. (2016). The case test-negative design for studies of the effectiveness of influenza vaccine in inpatient settings. International journal of epidemiology, 45(6)

Lin L, Pan Y, Hedayat AS, Barnhart HX, Haber M. (2015). A simulation study of nonparametric total deviation index as a measure of agreement based on quantile regression. Journal of biopharmaceutical statistics, 26(5)

Haber P, Parashar UD, Haber M, DeStefano F. (2015). Intussusception after monovalent rotavirus vaccine-United States, Vaccine Adverse Event Reporting System (VAERS), 2008-2014. Vaccine, 33(38)

Haber M, Levin BR, Kramarz P. (2010). Antibiotic control of antibiotic resistance in hospitals: a simulation study. BMC infectious diseases, (10)

Haber M, Gao J, Barnhart HX. (2010). Evaluation of Agreement between Measurement Methods from Data with Matched Repeated Measurements via the Coefficient of Individual Agreement. Journal of data science : JDS, 8(3)

Haber M, Barskey A, Baughman W, Barker L, Whitney CG, Shaw KM, Orenstein W, Stephens DS. (2007). Herd immunity and pneumococcal conjugate vaccine: a quantitative model. Vaccine, 25(29)

Haber M, Barnhart HX. (2008). A general approach to evaluating agreement between two observers or methods of measurement from quantitative data with replicated measurements. Statistical methods in medical research, 17(2)

Haber M, Gao J, Barnhart HX. Assessing observer agreement in studies involving replicated binary observations. Journal of biopharmaceutical statistics, 17(4)

Haber MJ, Shay DK, Davis XM, Patel R, Jin X, Weintraub E, Orenstein E, Thompson WW. (2007). Effectiveness of interventions to reduce contact rates during a simulated influenza pandemic. Emerging infectious diseases, 13(4)

Haber M, Barnhart HX. (2006). Coefficients of agreement for fixed observers. Statistical methods in medical research, 15(3)

Haber M, Watelet L, Halloran ME. (1995). On individual and population effectiveness of vaccination. International journal of epidemiology, 24(6)

Haber M, Longini IM Jr., Halloran ME. (1991). Measures of the effects of vaccination in a randomly mixing population. International journal of epidemiology, 20(1)

Haber M, Longini IM Jr., Halloran ME. (1991). Estimation of vaccine efficacy in outbreaks of acute infectious diseases. Statistics in medicine, 10(10)

If you’d like to update your profile, please email modifications to

This site is registered on as a development site.